Project Details
| Status | Active |
|---|---|
| Effective start/end date | 6/08/25 → 5/08/27 |
Keywords
- Clinical Trial
- NVG-2089-201
Clinical Trial Phase
- Phase II
A Phase 2, Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous NVG-2089 in Participants with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Pham, Xiuxian (Primary Chief Investigator (PCI))
Project: Research